-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: What are the characteristics of brain in situ models?
Author:
InnoModels
Release time:
2024-06-12
In the field of life sciences, brain science has always been a fascinating and challenging research direction. In order to deeply explore the complex structure and function of the brain, as well as to better simulate and understand the operation mechanism of the nervous system, scientists have been striving to find and develop more advanced research tools and methods. In recent years, the emergence of the brain in-situ modeling technology from InnoModels Biotechnology has brought new breakthroughs and opportunities in the field of brain science research.
InnoModels' in-situ brain model is an advanced technology capable of restoring the in-situ structure of brain tissue. Based on the latest bioengineering and nanotechnology, it can accurately simulate the neuronal connections and distribution in the brain, thus constructing a highly realistic model of brain tissue. This feature enables researchers to conduct deeper and more detailed studies under conditions that are closer to the real brain environment.
First of all, one of the best features of the InnoModels BioBrain in-situ modeling technology is its ability to restore the in-situ structure of the brain tissue. In the brain, neurons are connected to each other through a complex network to form a highly organized structure, and these structures play a crucial role in the functioning of the brain. Traditional brain slicing or cell culture methods often fail to fully preserve this complex connectivity, thus limiting the depth and breadth of research. In contrast, the InnoModels BioBrain in situ model is able to preserve the neuronal connections and distribution, allowing researchers to study under conditions closer to the real thing, and thus better understand the complex functions of the brain.

Second, InnoModels' in situ brain modeling technology shows great potential for disease modeling. Neurological diseases such as Alzheimer's disease and Parkinson's disease have been difficult challenges for the medical community to overcome. The pathogenesis of these diseases is complex and involves biological processes at multiple levels, making it difficult to simulate them under a single experimental condition. In contrast, InnoModels' brain in-situ modeling technology can construct brain tissue models with specific disease characteristics, providing researchers with the possibility of conducting studies in an environment closer to the real disease. Through these models, scientists can deeply explore the pathogenesis of diseases and provide strong support for finding new treatments and drugs.
In addition, InnoModels' in situ brain modeling technology can be used as a platform for drug testing. Assessing the effects of new drugs on brain function is a crucial part of the drug development process. However, it is often difficult for traditional drug testing methods to accurately reflect the effects of drugs in the real brain environment. In contrast, InnoModels' in situ brain models simulate the structure and function of the brain, allowing researchers to conduct drug testing under conditions that are closer to the real thing. Through this technology, researchers can assess the effects of new drugs on neuronal activity, signaling and other aspects, providing more accurate predictions and more reliable data support for drug development.
In summary, with its unique advantages and potentials, InnoModels' in situ brain modeling technology has brought a revolutionary breakthrough in the field of brain science research. It can not only restore the in-situ structure of brain tissues, providing researchers with research conditions closer to the real brain environment; it can also be used to establish a variety of neurological disease models, providing a powerful tool for the study of disease mechanisms; at the same time, it can be used as a platform for drug testing, providing more accurate predictions and more reliable data support for drug research and development. It is believed that with the continuous development and improvement of this technology, we will have a deeper understanding of the mysteries of the brain and open up a broader path for the development of neuroscience and medicine.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd